AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58
CARBOPLATIN DOSAGE FORMULAS CAN GENERATE INACCURATE PREDICTIONS OF CARBOPLATIN EXPOSURE IN CARBOPLATIN PACLITAXEL COMBINATION REGIMENS/
Authors: PANDAY VRN VANWARMERDAM LJC HUIZING MT HUININK WWT VERMORKEN JB GIACCONE G VEENHOF CHN SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., CARBOPLATIN DOSAGE FORMULAS CAN GENERATE INACCURATE PREDICTIONS OF CARBOPLATIN EXPOSURE IN CARBOPLATIN PACLITAXEL COMBINATION REGIMENS/, Clinical drug investigation, 15(4), 1998, pp. 327-335
SENSITIVE DETERMINATION OF THE CARBOXYLATE AND LACTONE FORMS OF THE NOVEL ANTITUMOR DRUG IRINOTECAN AND ITS ACTIVE METABOLITE IN PLASMA BY HPLC
Authors: HERBEN VMM MAZEE D VANGORTELVANZOMEREN DM ZEEDIJK S ROSING H SCHELLENS JHM HUININK WWT BEIJNEN JH
Citation: Vmm. Herben et al., SENSITIVE DETERMINATION OF THE CARBOXYLATE AND LACTONE FORMS OF THE NOVEL ANTITUMOR DRUG IRINOTECAN AND ITS ACTIVE METABOLITE IN PLASMA BY HPLC, Journal of liquid chromatography & related technologies, 21(10), 1998, pp. 1541-1558
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS GJH BURRIS H SCHELLENS JHM ECKARDT JR PLANTING AST VANDERBURG MEL RODRIGUEZ GI LOOS WJ VANBEURDEN V HUDSON I FIELDS S VONHOFF DD VERWEIJ J
Citation: Gjh. Gerrits et al., ORAL TOPOTECAN GIVEN ONCE OR TWICE-DAILY FOR 10 DAYS - A PHASE-I PHARMACOLOGY STUDY IN ADULT PATIENTS WITH SOLID TUMORS, Clinical cancer research, 4(5), 1998, pp. 1153-1158
PHARMACOLOGICAL STUDY OF 3-HOUR 135 MG M(-2) PACLITAXEL IN PLATINUM PRETREATED PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: PANDAY VRN HUIZING MT VANWARMERDAM LJC DUBBELMAN RC MANDJES I SCHELLENS JHM HUININK WWT BEIJNEN JH
Citation: Vrn. Panday et al., PHARMACOLOGICAL STUDY OF 3-HOUR 135 MG M(-2) PACLITAXEL IN PLATINUM PRETREATED PATIENTS WITH ADVANCED OVARIAN-CANCER, Pharmacological research, 38(3), 1998, pp. 231-236
CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPY
Authors: KUIPER RAJ SCHELLENS JHM BLIJHAM GH BEIJNEN JH VOEST EE
Citation: Raj. Kuiper et al., CLINICAL RESEARCH ON ANTIANGIOGENIC THERAPY, Pharmacological research, 37(1), 1998, pp. 1-16
5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS
Authors: GERRITS CJH BURRIS H SCHELLENS JHM PLANTING AST VANDENBURG MEL RODRIGUEZ GI VANBEURDEN V LOOS WJ HUDSON I FIELDS S VERWEIJ J VONHOFF DD
Citation: Cjh. Gerrits et al., 5 DAYS OF ORAL TOPOTECAN (HYCAMTIN(R)), A PHASE-I AND PHARMACOLOGICALSTUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 34(7), 1998, pp. 1030-1035
PHASE-II STUDY ON CISPLATIN AND IFOSFAMIDE IN RECURRENT HIGH-GRADE GLIOMAS
Authors: VANDENBENT MJ SCHELLENS JHM VECHT CJ SMIT PAES LOOSVELD OJL MA J TIJSSEN CC JANSEN RLH KROS JM VERWEIJ J
Citation: Mj. Vandenbent et al., PHASE-II STUDY ON CISPLATIN AND IFOSFAMIDE IN RECURRENT HIGH-GRADE GLIOMAS, European journal of cancer, 34(10), 1998, pp. 1570-1574
PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY DOXORUBICIN AND 1 HR INFUSIONAL PACLITAXEL IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: PANDAY VRN HUININK WWT ROSING H KOOPMAN FJ HILLEBRAND MJX DUBBELMAN RC VANTELLINGEN O SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY DOXORUBICIN AND 1 HR INFUSIONAL PACLITAXEL IN PATIENTS WITH ADVANCED BREAST-CANCER, Anti-cancer drugs, 9(8), 1998, pp. 665-673
CLINICAL PHARMACOKINETICS OF CAMPTOTHECIN TOPOISOMERASE-I INHIBITORS
Authors: HERBEN VMM HUININK WWT SCHELLENS JHM BEIJNEN JH
Citation: Vmm. Herben et al., CLINICAL PHARMACOKINETICS OF CAMPTOTHECIN TOPOISOMERASE-I INHIBITORS, Pharmacy world & science, 20(4), 1998, pp. 161-172
A NEW ORAL DOSAGE FORM OF TOPOTECAN - BIOAVAILABILITY AND EFFECT OF FOOD COADMINISTRATION
Authors: HERBEN VMM SCHELLENS JHM HUININK WWT ROSING H VANZOMEREN DM BEUSENBERG FB ROSS G BEIJNEN JH
Citation: Vmm. Herben et al., A NEW ORAL DOSAGE FORM OF TOPOTECAN - BIOAVAILABILITY AND EFFECT OF FOOD COADMINISTRATION, Annals of oncology, 9, 1998, pp. 227-227
PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY BOLUS DOXORUBICIN AND 1-HOUR PACLITAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: PANDAY VRN HUININK WWT ROSING H VANTELLINGEN O SCHELLENS JHM BEIJNEN JH
Citation: Vrn. Panday et al., PHASE-I AND PHARMACOLOGICAL STUDY OF WEEKLY BOLUS DOXORUBICIN AND 1-HOUR PACLITAXEL IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 9, 1998, pp. 368-368
COADMINISTRATION OF CYCLOSPORINE-A INTERFERES WITH PACLITAXEL METABOLISM IN HUMANS
Authors: MALINGRE MM TERWOGT JMM SCHELLENS JHM DUCHIN K ROSING H BEIJNEN JH
Citation: Mm. Malingre et al., COADMINISTRATION OF CYCLOSPORINE-A INTERFERES WITH PACLITAXEL METABOLISM IN HUMANS, Annals of oncology, 9, 1998, pp. 369-369
COADMINISTRATION OF CYCLOSPORINE-A (CSA) ENABLES ORAL-THERAPY WITH PACLITAXEL (PAC)
Authors: TERWOGT JMM BEIJNEN JH HUININK WT ROSING H VANTELLINGEN O SWART M DUCHIN J SCHELLENS JHM
Citation: Jmm. Terwogt et al., COADMINISTRATION OF CYCLOSPORINE-A (CSA) ENABLES ORAL-THERAPY WITH PACLITAXEL (PAC), Annals of oncology, 9, 1998, pp. 379-379
PHASE-I AND PHARMACOLOGICAL STUDY OF SPI-77, A NEW LIPOSOMAL ENCAPSULATED FORMULATION OF CISPLATIN (CDDP)
Authors: TERWOGT JMM BEIJNEN JH HUININK WWT MALIEPAARD M TIBBEN M WELBANK H GROENEWEGEN G SCHELLENS JHM
Citation: Jmm. Terwogt et al., PHASE-I AND PHARMACOLOGICAL STUDY OF SPI-77, A NEW LIPOSOMAL ENCAPSULATED FORMULATION OF CISPLATIN (CDDP), Annals of oncology, 9, 1998, pp. 464-464
PHASE-II WITH UFT PLUS FOLINIC ACID (FA) IN PATIENTS WITH METASTATIC GASTRIC-CANCER
Authors: RAVAUD A BORNER M SCHELLENS JHM GEOFFROIS L SCHOFFSKI P WANDERS J HANAUSKE AR
Citation: A. Ravaud et al., PHASE-II WITH UFT PLUS FOLINIC ACID (FA) IN PATIENTS WITH METASTATIC GASTRIC-CANCER, Annals of oncology, 9, 1998, pp. 626-626
SYNERGISTIC CYTOTOXICITY OF CISPLATIN AND TOPOTECAN OR SN-38 IN A PANEL OF 8 SOLID-TUMOR CELL-LINES IN-VITRO
Authors: MA JG MALIEPAARD M NOTTER K BOERSMA AWM VERWEIJ J STOTER G SCHELLENS JHM
Citation: Jg. Ma et al., SYNERGISTIC CYTOTOXICITY OF CISPLATIN AND TOPOTECAN OR SN-38 IN A PANEL OF 8 SOLID-TUMOR CELL-LINES IN-VITRO, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 307-316
ABROGATED ENERGY-DEPENDENT UPTAKE OF CISPLATIN IN A CISPLATIN-RESISTANT SUBLINE OF THE HUMAN OVARIAN-CANCER CELL-LINE IGROV-1
Authors: MA JG MALIEPAARD M KOLKER HJ VERWEIJ J SCHELLENS JHM
Citation: Jg. Ma et al., ABROGATED ENERGY-DEPENDENT UPTAKE OF CISPLATIN IN A CISPLATIN-RESISTANT SUBLINE OF THE HUMAN OVARIAN-CANCER CELL-LINE IGROV-1, Cancer chemotherapy and pharmacology, 41(3), 1998, pp. 186-192
IN-VITRO METABOLISM OF ANTICANCER DRUGS, METHODS AND APPLICATIONS - PACLITAXEL, DOCETAXEL, TAMOXIFEN AND IFOSFAMIDE
Authors: CROMMENTUYN KML SCHELLENS JHM VANDENBERG JD BEIJNEN JH
Citation: Kml. Crommentuyn et al., IN-VITRO METABOLISM OF ANTICANCER DRUGS, METHODS AND APPLICATIONS - PACLITAXEL, DOCETAXEL, TAMOXIFEN AND IFOSFAMIDE, Cancer treatment reviews, 24(5), 1998, pp. 345-366
THE EFFECT OF DEXAMETHASONE ON THE UPTAKE OF CISPLATIN IN 9L GLIOMA AND THE AREA OF BRAIN AROUND TUMOR
Authors: STRAATHOF CSM VANDENBENT MJ MA J SCHMITZ PIM KROS JM STOTER G VECHT CJ SCHELLENS JHM
Citation: Csm. Straathof et al., THE EFFECT OF DEXAMETHASONE ON THE UPTAKE OF CISPLATIN IN 9L GLIOMA AND THE AREA OF BRAIN AROUND TUMOR, Journal of neuro-oncology, 37(1), 1998, pp. 1-8
COADMINISTRATION OF CYCLOSPORINE ENABLES ORAL-THERAPY WITH PACLITAXEL
Authors: TERWOGT JMM BEIJNEN JH HUININK WWT ROSING H SCHELLENS JHM
Citation: Jmm. Terwogt et al., COADMINISTRATION OF CYCLOSPORINE ENABLES ORAL-THERAPY WITH PACLITAXEL, Lancet, 352(9124), 1998, pp. 285-285
DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS - RESULTS OF A PHASE-I STUDY
Authors: PRONK LC SCHRIJVERS D SCHELLENS JHM DEBRUIJN EA PLANTING AST LOCCITONELLI D GROULT V VERWEIJ J VANOOSTEROM AT
Citation: Lc. Pronk et al., DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS - RESULTS OF A PHASE-I STUDY, Seminars in oncology, 25(1), 1998, pp. 23-28
REDUCED CELLULAR ACCUMULATION OF TOPOTECAN - A NOVEL MECHANISM OF RESISTANCE IN A HUMAN OVARIAN-CANCER CELL-LINE
Authors: MA J MALIEPAARD M NOOTER K LOOS WJ KOLKER HJ VERWEIJ J STOTER G SCHELLENS JHM
Citation: J. Ma et al., REDUCED CELLULAR ACCUMULATION OF TOPOTECAN - A NOVEL MECHANISM OF RESISTANCE IN A HUMAN OVARIAN-CANCER CELL-LINE, British Journal of Cancer, 77(10), 1998, pp. 1645-1652
PHASE-I STUDY ON DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: PRONK LC SCHRIJVERS D SCHELLENS JHM DEBRUIJN EA PLANTING AST LOCCITONELLI D GROULT V VERWEIJ J VANOOSTEROM AT
Citation: Lc. Pronk et al., PHASE-I STUDY ON DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS, British Journal of Cancer, 77(1), 1998, pp. 153-158
DETERMINATION OF THE LACTONE AND LACTONE PLUS CARBOXYLATE FORMS OF 9-AMINOCAMPTOTHECIN IN HUMAN PLASMA BY SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
Authors: LOOS WJ SPARREBOOM A VERWEIJ J NOOTER K STOTER G SCHELLENS JHM
Citation: Wj. Loos et al., DETERMINATION OF THE LACTONE AND LACTONE PLUS CARBOXYLATE FORMS OF 9-AMINOCAMPTOTHECIN IN HUMAN PLASMA BY SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of chromatography B. Biomedical sciences and applications, 694(2), 1997, pp. 435-441
Risultati: 1-25 | 26-50 | 51-58